Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy

Author:

Zhao Xiujuan,Lin Xiaojing,Li Ping,Chen Zinuo,Zhang Chengcheng,Manicassamy Balaji,Rong Lijun,Cui Qinghua,Du RuikunORCID

Abstract

Reporter viruses provide powerful tools for both basic and applied virology studies, however, the creation and exploitation of reporter influenza A viruses (IAVs) have been hindered by the limited tolerance of the segmented genome to exogenous modifications. Interestingly, our previous study has demonstrated the underlying mechanism that foreign insertions reduce the replication/transcription capacity of the modified segment, impairing the delicate balance among the multiple segments during IAV infection. In the present study, we developed a “balance compensation” strategy by incorporating additional compensatory mutations during initial construction of recombinant IAVs to expand the tolerance of IAV genome. As a proof of concept, promoter-enhancing mutations were introduced within the modified segment to rectify the segments imbalance of a reporter influenza PR8-NS-Gluc virus, while directed optimization of the recombinant IAV was successfully achieved. Further, we generated recombinant IAVs expressing a much larger firefly luciferase (Fluc) by coupling with a much stronger compensatory enhancement, and established robust Fluc-based live-imaging mouse models of IAV infection. Our strategy feasibly expands the tolerance for foreign gene insertions in the segmented IAV genome, which opens up better opportunities to develop more versatile reporter IAVs as well as live attenuated influenza virus-based vaccines for other important human pathogens.

Funder

National Natural Science Foundation of China

Key Technology Research and Development Program of Shandong

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference39 articles.

1. WHO. 2018 Influenza (seasonal) fact sheet. WHO, Geneva, Switzerland. 2018;http://www.who.int/mediacentre/factsheets/fs211/en/.

2. Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance;J Han;Current medicinal chemistry,2018

3. Baloxavir Marboxil: The First Cap-Dependent Endonuclease Inhibitor for the Treatment of Influenza;T. Yang;Ann Pharmacother,2019

4. Influenza and antiviral resistance: an overview;T Lampejo;Eur J Clin Microbiol Infect Dis,2020

5. In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies;NS Heaton;J Virol,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3